E12A Principles for Clinical Evaluation of New Antihypertensive Drugs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 9, 2000
April 20, 2020
a715b1f0-1946-46b1-8a7f-cd01a428224d
Related Documents
E6(R3) Good Clinical Practice: Annex 2
Guidance DocumentDecember 30, 2024Center for Drug Evaluation and Research
M15 General Principles for Model-Informed Drug Development
Guidance DocumentDecember 30, 2024Center for Drug Evaluation and Research
M5International Conference on Harmonisation; Draft Guidance on M5 Data Elements and Standards for Drug Dictionaries
Guidance DocumentSeptember 6, 2005Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.